Heart failure clinical trials
2,872 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all heart failure studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting heart failure studies. A study counts once in each state where it has a site.
- California247
- Texas235
- New York220
- Ohio204
- Florida189
- Massachusetts182
- Pennsylvania174
- Minnesota167
- North Carolina164
- Michigan152
- Illinois144
- Tennessee138
Also in China (432), France (337), Italy (263), Germany (262), Canada (233), United Kingdom (206), Spain (199), South Korea (152).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 120
- Phase 148
- Phase 1 / Phase 243
- Phase 2167
- Phase 2 / Phase 325
- Phase 3175
- Phase 4169
- No phase (devices, programs)1,137
- Observational1,088
Recently updated studies
Recruiting heart failure studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 3NCT06172296
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ages Up to 30 Years · Birmingham, Alabama · Mobile, Alabama +149 more · National Cancer Institute (NCI)
- RecruitingPhase 2NCT07215273
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
Ages 18 Years and over · Birmingham, Alabama · Sacramento, California +25 more · Elion Therapeutics, Inc.
- RecruitingPhase 2NCT06124157
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ages 366 Days – 46 Years · Birmingham, Alabama · Phoenix, Arizona +137 more · National Cancer Institute (NCI)
- RecruitingPhase 1NCT06090669
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Ages 18 Years – 120 Years · Bethesda, Maryland · National Cancer Institute (NCI)
- RecruitingNo phase (devices, programs)NCT07438015
VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit
Ages 18 Years and over · Besançon, France · Centre Hospitalier Universitaire de Besancon
- RecruitingNo phase (devices, programs)NCT07449377
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Ages 18 Years and over · Paris, France · Assistance Publique - Hôpitaux de Paris
- RecruitingPhase 3NCT07192952
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Ages Up to 18 Years · Aurora, Colorado · Wilmington, Delaware +111 more · Bayer
- RecruitingNo phase (devices, programs)NCT07411768
Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement
Ages 60 Years – 85 Years · Beijing, China · China National Center for Cardiovascular Diseases
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.